Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst ...

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who ...

The S&P 500 slipped 0.6% on Wednesday, May 28, ahead of semiconductor giant Nvidia's highly anticipated quarterly earnings ...

Stocks face volatility as concerns over U.S. government debt mount, with the S&P 500 potentially headed for its worst week in ...

WASHINGTON-House Republicans made a series of last-minute changes to their sprawling tax-and-spending bill, searching for a path that could unite the party's warring wings headed into a nail-biter ...

UnitedHealth said in a statement late Wednesday that the Department of Justice hadn’t notified the company about the reported ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

S&P 500 E-Mini futures (ESM25) are down -0.05%, andJune Nasdaq 100 E-Mini futures (NQM25) are down -0.09% this morning as ...

U.S. equities edged higher midday after the House passed the big tax and spending package supported by President Trump.

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Humana's options at certain strike prices.

JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Robert W. Baird ...